023410 — EUGENE Balance Sheet
0.000.00%
- KR₩234bn
- KR₩1tn
- KR₩1tn
- 12
- 91
- 66
- 61
Annual balance sheet for EUGENE, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 477,811 | 169,627 | 121,584 | 229,966 | 206,810 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 252,869 | 251,592 | 262,284 | 293,637 | 248,943 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 763,499 | 860,320 | 485,501 | 622,426 | 555,662 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 456,705 | 465,556 | 499,574 | 522,011 | 530,511 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 4,708,657 | 2,276,820 | 2,030,422 | 2,286,216 | 2,374,868 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 737,982 | 1,094,053 | 698,286 | 987,297 | 854,712 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 3,907,912 | 1,398,563 | 1,137,806 | 1,301,460 | 1,492,578 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 800,746 | 878,257 | 892,616 | 984,756 | 882,290 |
| Total Liabilities & Shareholders' Equity | 4,708,657 | 2,276,820 | 2,030,422 | 2,286,216 | 2,374,868 |
| Total Common Shares Outstanding |